Skip to main content
Top
Published in: BMC Nephrology 1/2011

Open Access 01-12-2011 | Research article

Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study

Authors: Johann Cailhol, Béatrice Nkurunziza, Hassan Izzedine, Emmanuel Nindagiye, Laurence Munyana, Evelyne Baramperanye, Janvière Nzorijana, Désiré Sakubu, Théodore Niyongabo, Olivier Bouchaud

Published in: BMC Nephrology | Issue 1/2011

Login to get access

Abstract

Background

Since little is known about chronic kidney disease (CKD) among people living with HIV/AIDS (PLWHA) in Sub-Saharan Africa, the prevalence and nature of CKD were assessed in Burundi through a multicenter cross-sectional study.

Methods

Patients underwent assessments at baseline and 3 months later. Glomerular Filtration Rate (GFR) was estimated using abbreviated 4-variable Modification of Diet in Renal Diseases (MDRD) and Cockroft-Gault estimation methods. Patients were classified at month 3 into various CKD stages using the National Kidney Foundation (NKF) definition, which combines GFR and urinary abnormalities. Risk factors for presence of proteinuria (PRO) and aseptic leukocyturia (LEU) were further analyzed using multiple logistic regression.

Results

Median age of the patients in the study (N = 300) was 40 years, 70.3% were female and 71.7% were on highly active antiretroviral therapy. Using the MDRD method, CKD prevalence in patients was 45.7%, 30.2% of whom being classified as stage 1 according to the NKF classification, 13.5% as stage 2 and 2% as stage 3. No patient was classified as stage 4 or 5. Among CKD patients with urinary abnormality, PRO accounted for 6.1% and LEU for 18.4%. Significant associations were found between LEU and non-steroidal anti-inflammatory drug (NSAID) use, previous history of tuberculosis, low body mass index and female gender and between PRO and high viral load.

Conclusion

Our study, using a very sensitive definition for CKD evaluation, suggests a potentially high prevalence of CKD among PLWHA in Burundi. Patients should be regularly monitored and preventative measures implemented, such as monitoring NSAID use and adjustment of drug dosages according to body weight. Urine dipsticks could be used as a screening tool to detect patients at risk of renal impairment.
Appendix
Available only for authorised users
Literature
1.
go back to reference Winston J, Deray G, Hawkins T, et al: Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008, 47 (11): 1449-57. 10.1086/593099.CrossRefPubMed Winston J, Deray G, Hawkins T, et al: Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008, 47 (11): 1449-57. 10.1086/593099.CrossRefPubMed
2.
go back to reference Ross MJ, Klotman PE: HIV-associated nephropathy. AIDS (London, England). 2004, 18 (8): 1089-99. 10.1097/00002030-200405210-00002.CrossRef Ross MJ, Klotman PE: HIV-associated nephropathy. AIDS (London, England). 2004, 18 (8): 1089-99. 10.1097/00002030-200405210-00002.CrossRef
3.
go back to reference Wools-Kaloustian KK, Gupta SK: Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney Int. 2008, 74 (7): 845-7. 10.1038/ki.2008.326.CrossRefPubMed Wools-Kaloustian KK, Gupta SK: Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney Int. 2008, 74 (7): 845-7. 10.1038/ki.2008.326.CrossRefPubMed
4.
go back to reference Lucas GM, Lau B, Atta MG, et al: Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008, 197 (11): 1548-57. 10.1086/587994.CrossRefPubMedPubMedCentral Lucas GM, Lau B, Atta MG, et al: Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008, 197 (11): 1548-57. 10.1086/587994.CrossRefPubMedPubMedCentral
5.
go back to reference Wyatt CM: HIV and the kidney: a spotlight on racial disparities. J Infect Dis. 2008, 197 (11): 1490-2. 10.1086/587995.CrossRefPubMed Wyatt CM: HIV and the kidney: a spotlight on racial disparities. J Infect Dis. 2008, 197 (11): 1490-2. 10.1086/587995.CrossRefPubMed
6.
go back to reference Allison SJ: The renal complications of HIV. Nature Rev. 2009, 5 (10): 545- Allison SJ: The renal complications of HIV. Nature Rev. 2009, 5 (10): 545-
7.
go back to reference Fabian J, Naicker S: HIV and kidney disease in sub-Saharan Africa. Nature Rev. 2009, 5 (10): 591-8. Fabian J, Naicker S: HIV and kidney disease in sub-Saharan Africa. Nature Rev. 2009, 5 (10): 591-8.
8.
go back to reference Emem CP, Arogundade F, Sanusi A, et al: Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008, 23 (2): 741-6.CrossRefPubMed Emem CP, Arogundade F, Sanusi A, et al: Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008, 23 (2): 741-6.CrossRefPubMed
9.
go back to reference Han TM, Naicker S, Ramdial PK, et al: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006, 69 (12): 2243-50. 10.1038/sj.ki.5000339.CrossRefPubMed Han TM, Naicker S, Ramdial PK, et al: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int. 2006, 69 (12): 2243-50. 10.1038/sj.ki.5000339.CrossRefPubMed
10.
go back to reference Peters PJ, Moore DM, Mermin J, et al: Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008, 74 (7): 925-9. 10.1038/ki.2008.305.CrossRefPubMed Peters PJ, Moore DM, Mermin J, et al: Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int. 2008, 74 (7): 925-9. 10.1038/ki.2008.305.CrossRefPubMed
11.
go back to reference Wools-Kaloustian K, Gupta SK, Muloma E, et al: Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant. 2007, 22 (8): 2208-12. 10.1093/ndt/gfm223.CrossRefPubMed Wools-Kaloustian K, Gupta SK, Muloma E, et al: Renal disease in an antiretroviral-naive HIV-infected outpatient population in Western Kenya. Nephrol Dial Transplant. 2007, 22 (8): 2208-12. 10.1093/ndt/gfm223.CrossRefPubMed
12.
go back to reference Andia I, Pepper L, Matheison P: Prevalence Of Renal Disease In Patients Attending The HIV/AIDS Clinic, At Mbarara University Teaching Hospital. The 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005 Andia I, Pepper L, Matheison P: Prevalence Of Renal Disease In Patients Attending The HIV/AIDS Clinic, At Mbarara University Teaching Hospital. The 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005
13.
go back to reference Arogundade F, Emem-Chioma P, Sanusi A, et al: Renal dysfunction and HIV associated nephropathy (HIVAN) in Nigerians: prevalence, clinical features and histopathology. XVI International AIDS Conference. 2006 Arogundade F, Emem-Chioma P, Sanusi A, et al: Renal dysfunction and HIV associated nephropathy (HIVAN) in Nigerians: prevalence, clinical features and histopathology. XVI International AIDS Conference. 2006
14.
go back to reference Muloma E, Owino-Ong'or W, Sidle J, et al: Renal disease in an antiretroviral naïve HIV-infected population in western Kenya. The 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005 Muloma E, Owino-Ong'or W, Sidle J, et al: Renal disease in an antiretroviral naïve HIV-infected population in western Kenya. The 3rd IAS Conference on HIV Pathogenesis and Treatment. 2005
16.
go back to reference Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med. 1999, 130 (6): 461-70.CrossRefPubMed Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Int Med. 1999, 130 (6): 461-70.CrossRefPubMed
17.
go back to reference Dubois D, Dubois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Int Med. 1916, 863-71. 17 Dubois D, Dubois EF: A formula to estimate the approximate surface area if height and weight be known. Arch Int Med. 1916, 863-71. 17
18.
go back to reference Behar DM, Shlush LI, Maor C, et al: Absence of HIV-associated nephropathy in Ethiopians. Am J Kidney Dis. 2006, 47 (1): 88-94. 10.1053/j.ajkd.2005.09.023.CrossRefPubMed Behar DM, Shlush LI, Maor C, et al: Absence of HIV-associated nephropathy in Ethiopians. Am J Kidney Dis. 2006, 47 (1): 88-94. 10.1053/j.ajkd.2005.09.023.CrossRefPubMed
19.
go back to reference Fernando SK, Finkelstein FO, Moore BA, et al: Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008, 335 (2): 89-94. 10.1097/MAJ.0b013e31812e6b34.CrossRefPubMed Fernando SK, Finkelstein FO, Moore BA, et al: Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008, 335 (2): 89-94. 10.1097/MAJ.0b013e31812e6b34.CrossRefPubMed
20.
go back to reference Sorli ML, Guelar A, Montero M, et al: Chronic kidney disease prevalence and risk factors among HIV-infected patients. Journal Acquir Immune Defic Syndr (1999). 2008, 48 (4): 506-8. 10.1097/QAI.0b013e31817bbecb.CrossRef Sorli ML, Guelar A, Montero M, et al: Chronic kidney disease prevalence and risk factors among HIV-infected patients. Journal Acquir Immune Defic Syndr (1999). 2008, 48 (4): 506-8. 10.1097/QAI.0b013e31817bbecb.CrossRef
21.
go back to reference Overton ET, Nurutdinova D, Freeman J, et al: Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009, 10 (6): 343-50. 10.1111/j.1468-1293.2009.00693.x.CrossRefPubMedPubMedCentral Overton ET, Nurutdinova D, Freeman J, et al: Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009, 10 (6): 343-50. 10.1111/j.1468-1293.2009.00693.x.CrossRefPubMedPubMedCentral
22.
go back to reference Kalayjian RC, Franceschini N, Gupta SK, et al: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS (London, England). 2008, 22 (4): 481-7. 10.1097/QAD.0b013e3282f4706d.CrossRef Kalayjian RC, Franceschini N, Gupta SK, et al: Suppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney disease. AIDS (London, England). 2008, 22 (4): 481-7. 10.1097/QAD.0b013e3282f4706d.CrossRef
23.
go back to reference Stohr W, Walker AS, Munderi P, DART Trial, et al: Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther. 2008, 13 (6): 761-70.PubMed Stohr W, Walker AS, Munderi P, DART Trial, et al: Estimating glomerular filtration rate in HIV-infected adults in Africa: comparison of Cockcroft-Gault and Modification of Diet in Renal Disease formulae. Antivir Ther. 2008, 13 (6): 761-70.PubMed
24.
go back to reference Hsieh HC, Lu PL, Chen YH, et al: Genitourinary tuberculosis in a medical center in southern Taiwan: an eleven-year experience. J Microbiol Immunol Infect. 2006, 39 (5): 408-13.PubMed Hsieh HC, Lu PL, Chen YH, et al: Genitourinary tuberculosis in a medical center in southern Taiwan: an eleven-year experience. J Microbiol Immunol Infect. 2006, 39 (5): 408-13.PubMed
25.
go back to reference Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999, 106 (5B): 13S-24S.CrossRefPubMed Whelton A: Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. Am J Med. 1999, 106 (5B): 13S-24S.CrossRefPubMed
26.
go back to reference Fabian J, Naicker S, Venter WDF, et al: Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management-a single-center study in South Africa. Ethn Dis. 2009, 19 (S1): 80-5. Fabian J, Naicker S, Venter WDF, et al: Urinary screening abnormalities in antiretroviral-naive HIV-infected outpatients and implications for management-a single-center study in South Africa. Ethn Dis. 2009, 19 (S1): 80-5.
27.
go back to reference Szczech LA, Gange SJ, van der Horst C, et al: Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002, 61 (1): 195-202. 10.1046/j.1523-1755.2002.00094.x.CrossRefPubMed Szczech LA, Gange SJ, van der Horst C, et al: Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002, 61 (1): 195-202. 10.1046/j.1523-1755.2002.00094.x.CrossRefPubMed
28.
go back to reference Ross MJ, Klotman PE: Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002, 13 (12): 2997-3004. 10.1097/01.ASN.0000040750.40907.99.CrossRefPubMed Ross MJ, Klotman PE: Recent progress in HIV-associated nephropathy. J Am Soc Nephrol. 2002, 13 (12): 2997-3004. 10.1097/01.ASN.0000040750.40907.99.CrossRefPubMed
29.
go back to reference Wyatt CM, Morgello S, Katz-Malamed R, et al: The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 2009, 75 (4): 428-34. 10.1038/ki.2008.604.CrossRefPubMed Wyatt CM, Morgello S, Katz-Malamed R, et al: The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int. 2009, 75 (4): 428-34. 10.1038/ki.2008.604.CrossRefPubMed
30.
go back to reference Buitrago F, Calvo JI, Gomez-Jimenez C, et al: Comparison and agreement of the Cockroft-Gault and MDRD equaltions to estimate glomerular filtration rate in diagnosis of occult kidney disease. Nefrologia. 2008, 28 (3): 301-10.PubMed Buitrago F, Calvo JI, Gomez-Jimenez C, et al: Comparison and agreement of the Cockroft-Gault and MDRD equaltions to estimate glomerular filtration rate in diagnosis of occult kidney disease. Nefrologia. 2008, 28 (3): 301-10.PubMed
31.
go back to reference WHO: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. 2009, Geneva: World Health Organization WHO: Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. 2009, Geneva: World Health Organization
32.
go back to reference Chi BH, Mwango A, Giganti M, et al: Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. Journal Acquir Immune Defic Syndr. 1999, 54 (1): 63-70. Chi BH, Mwango A, Giganti M, et al: Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia. Journal Acquir Immune Defic Syndr. 1999, 54 (1): 63-70.
33.
go back to reference Gallant JE, Winston J, DeJesus E, et al: The 3-year safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretrovral-naive patients. AIDS (London, England). 2008, 22: 2155-63. 10.1097/QAD.0b013e3283112b8e.CrossRef Gallant JE, Winston J, DeJesus E, et al: The 3-year safety of a tenofovir disoproxil fumarate vs. a thymidine analogue-containing regimen in antiretrovral-naive patients. AIDS (London, England). 2008, 22: 2155-63. 10.1097/QAD.0b013e3283112b8e.CrossRef
34.
go back to reference Wever K, van Agtmael MA, Carr A: Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. Journal Acquir Immune Defic Syndr. 1999, 55 (1): 78-81.CrossRef Wever K, van Agtmael MA, Carr A: Incomplete reversibility of tenofovir-related renal toxicity in HIV-infected men. Journal Acquir Immune Defic Syndr. 1999, 55 (1): 78-81.CrossRef
Metadata
Title
Prevalence of chronic kidney disease among people living with HIV/AIDS in Burundi: a cross-sectional study
Authors
Johann Cailhol
Béatrice Nkurunziza
Hassan Izzedine
Emmanuel Nindagiye
Laurence Munyana
Evelyne Baramperanye
Janvière Nzorijana
Désiré Sakubu
Théodore Niyongabo
Olivier Bouchaud
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2011
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-12-40

Other articles of this Issue 1/2011

BMC Nephrology 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine